VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,483,000 | -76.8% | 170,450 | -10.2% | 2.78% | -74.3% |
| Q4 2015 | $19,298,000 | +27.5% | 189,850 | +123.7% | 10.85% | +4.7% |
| Q3 2015 | $15,140,000 | -8.7% | 84,875 | +13.7% | 10.36% | +1.9% |
| Q2 2015 | $16,589,000 | -1.4% | 74,675 | -11.8% | 10.17% | -0.9% |
| Q1 2015 | $16,823,000 | +24.1% | 84,700 | -10.6% | 10.27% | +25.7% |
| Q4 2014 | $13,553,000 | +9.1% | 94,700 | 0.0% | 8.16% | +14.2% |
| Q3 2014 | $12,425,000 | +21.3% | 94,700 | +16.6% | 7.15% | +17.8% |
| Q2 2014 | $10,242,000 | +94.2% | 81,210 | +103.0% | 6.07% | +91.3% |
| Q1 2014 | $5,273,000 | -10.2% | 40,000 | -20.0% | 3.18% | -14.8% |
| Q4 2013 | $5,870,000 | +12.5% | 50,000 | 0.0% | 3.73% | +2.1% |
| Q3 2013 | $5,216,000 | +21.2% | 50,000 | 0.0% | 3.65% | +23.9% |
| Q2 2013 | $4,304,000 | – | 50,000 | – | 2.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |